文献速递胸部肿瘤放疗放疗物理与技术

非小细胞肺癌放疗中肺与心脏剂量变异性研究

Lung and Heart Dose Variability During Radiation Therapy of Non-Small Cell Lung Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-03-08

该纵向研究对15例接受常规分割放化疗的肺癌患者每周行4维CT扫描,分析肺和心脏体积及剂量参数变化。结果显示分次间肺体积变异大于潮气量变异,下部肺叶变异更大,平均肺剂量和心脏剂量及V20Gy、V40Gy均出现变化。结论认为解剖和位置变异导致肺和心脏剂量改变,重复剂量评估有助于更准确估计实际递送剂量。

要点

  • 分次间肺体积变异是潮气量变异的2倍(8.0%±5.3% vs 4.0%±3.3%,P=.003)。
  • 下部肺叶体积变异大于上部肺叶(13.5%±8.1% vs 7.0%±5.0%,P<.00001)。
  • 平均心脏剂量变异1.2 Gy(范围0.1-3.0 Gy),心脏V40Gy变异1.4%(范围0%-4.2%)。

核心结论

  • 放疗期间的解剖和位置变异会导致肺和心脏照射剂量发生变化。
  • 重复评估肺和心脏剂量能更准确估计实际递送剂量,并可能改善正常组织毒性预测模型(需更大样本验证)。

研究设计与样本

  • 纵向研究,纳入15例接受常规分割放化疗的肺癌患者。
  • 每周行4维CT扫描,在中间呼吸时相勾画肿瘤、各肺叶和心脏,并在疗前、疗中和疗末扫描的各个呼吸时相勾画肺叶和心脏。
  • 通过刚性配准将计划剂量转移到连续扫描上,以初始计划扫描为参照评估体积和剂量变化。

主要发现

  • 分次间肺体积变异为8.0%±5.3%,潮气量变异为4.0%±3.3%(P=.003)。
  • 分次间肺体积变异患者均值范围为0.8%至17.1%。
  • 下部肺叶体积变异为13.5%±8.1%,上部肺叶为7.0%±5.0%(P<.00001)。
  • 平均肺剂量变异平均0.5 Gy(患者均值范围0.2-1.0 Gy),肺V20Gy变异平均0.9%(范围0.2%-1.6%)。
  • 心脏体积变异平均7.2%(范围3.4%-12.6%),平均心脏剂量变异平均1.2 Gy(范围0.1-3.0 Gy),心脏V40Gy变异平均1.4%(范围0%-4.2%)。

临床怎么用

  • 在肺癌放疗中应考虑分次间肺和心脏体积及位置变异对剂量的影响。
  • 可考虑重复进行肺和心脏剂量评估以更准确估计实际递送剂量。
  • 对于下部肺叶肿瘤或心脏受照患者,需关注更大的体积和剂量变异。

局限性

  • 样本量较小(15例患者)。
  • 结论中关于改善正常组织毒性预测模型需在更大队列中评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the hypothesis that positional and anatomic variations during radiation therapy induce changes in lung and heart volumes and associated radiation doses. METHODS AND MATERIALS: In this longitudinal investigation, variations in lung and heart volumes and standard dose parameters of mean lung dose, lung V20Gy, mean heart dose, and heart V40Gy were analyzed on weekly 4-dimensional CT scans of 15 lung cancer patients during conventionally fractionated radiochemotherapy. Tumor, individual lung lobes, and heart were delineated on the mid-ventilation phase of weekly 4-dimensional CT scans. Lung lobes and heart were also contoured on individual breathing phases of pre-, mid-, and end-of-treatment scans. Planning dose was transferred to consecutive scans via rigid registration. Volume and dose variations were assessed relative to the initial planning scan. RESULTS: Interfraction lung volume variability relative to week 0 was twice as large as tidal volume variability (8.0% ± 5.3% vs 4.0% ± 3.3%, P=.003). Interfraction lung volume variation ranged between 0.8% and 17.1% for individual patient means. Lower lung lobes had larger volume variability compared with upper lobes (13.5% ± 8.1% vs 7.0% ± 5.0%, P<.00001). Average mean lung dose variation was 0.5 Gy (range, 0.2-1.0 Gy for individual patient means) and average lung V20Gy variation 0.9% (range, 0.2%-1.6%). Average heart volume variation was 7.2% (range, 3.4%-12.6%). Average mean heart dose variation was 1.2 Gy (range, 0.1-3.0 Gy) and average heart V40Gy variation 1.4% (range, 0%-4.2%). CONCLUSIONS: Anatomic and positional variations during radiation therapy induce changes in radiation doses to lung and heart. Repeated lung and heart dose assessment will provide a better estimate of the actual delivered dose and will improve prediction models for normal tissue toxicity, if assessed in larger cohorts.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Jan N, Guy C, Reshko LB, et al. Lung and Heart Dose Variability During Radiation Therapy of Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017. PMID: 28581410. doi:10.1016/j.ijrobp.2017.02.227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。